Accès à distance ? S'identifier sur le proxy UCLouvain
Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2016 |
Language | Anglais |
Journal information | "Nuclear Medicine and Biology" - Vol. 43, no. 7, p. 415-423 (2016) |
Peer reviewed | yes |
Publisher | Elsevier Inc. ((United States) Philadelphia, PA) |
issn | 0969-8051 |
e-issn | 1872-9614 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - SSS/LDRI - Louvain Drug Research Institute UCL - (MGD) Service de médecine nucléaire UCL - (SLuc) Service de médecine nucléaire UCL - (SLuc) Service de radiothérapie oncologique |
Keywords | Anti-endoglin antibody ; CD105 ; Deiodination ; KRYRR ; SPECT/CT ; Tumor |
Links |
Bibliographic reference | Karmani, Linda ; Levêque, Philippe ; Bouzin, Caroline ; Bol, Anne ; Dieu, Marc ; et. al. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice.. In: Nuclear Medicine and Biology, Vol. 43, no. 7, p. 415-423 (2016) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/174114 |